About airis PHARMA
airis PHARMA is a company based in Hyderabad (India) founded in 2015. It operates as a B2B and Manufacturing. The company has 47 employees as of March 31, 2022. airis PHARMA offers products and services including Aminocaproic Acid Oral Solution, Generic Formulation Products, and Analytical Quality Services. airis PHARMA operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Hyderabad, India
- Employees 47 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Airis Pharma Private Limited
- Date of Incorporation 19 Aug, 2013
- Jurisdiction Quthbullapur Mandal, Telangana, India
-
Annual Revenue
$1.71 M (USD)261.33as on Mar 31, 2022
-
Net Profit
$190.41 K (USD)414.86as on Mar 31, 2022
-
EBITDA
$932.64 K (USD)1163.57as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
47
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of airis PHARMA
airis PHARMA offers a comprehensive portfolio of products and services, including Aminocaproic Acid Oral Solution, Generic Formulation Products, and Analytical Quality Services.
Prevents and treats excessive bleeding in surgical procedures.
Develops high-quality oral solids and injectables for global markets.
Conducts raw material and drug product testing for compliance.
Funding Insights of airis PHARMA
Detailed funding history for airis PHARMA
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by airis PHARMA
Investment portfolio details for airis PHARMA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - airis PHARMA
Detailed financials for airis PHARMA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Airis Pharma Comparisons
Peer comparison for airis PHARMA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of airis PHARMA
airis PHARMA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of airis PHARMA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Airis Pharma
Complete news archive for airis PHARMA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about airis PHARMA
airis PHARMA was founded in 2015.
airis PHARMA is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2022, the latest employee count at airis PHARMA is 47.
Annual revenue of airis PHARMA is $1.71M as on Mar 31, 2022.
airis PHARMA focuses on developing generic formulation products ranging from oral solids to injectables, emphasizing high entry barriers and continuous quality. Based in Hyderabad, India, it provides research and development services, analytical testing for raw materials and drug products, and stability storage under ICH conditions. The company targets markets such as the US, Europe, NZ-Aus, Turkey, and UK, with approvals like ANDA for specific drugs.
airis PHARMA's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
airis PHARMA offers Aminocaproic Acid Oral Solution, Generic Formulation Products, and Analytical Quality Services.